跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Berzimax-500
Approved
STANDARD
Berzimax-500
Gufic Biosciences Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
69f9801b0dc9c9be
Company
Gufic Biosciences Limited
Type
Standard
Approval Details
Approval Id
69f9801b0dc9c9be
Drug Approval Philippines Name
Berzimax-500
Product Name
Berzimax-500
Registration Number
DRP-4354-05
Brand Name
Berzimax-500
Generic Name
Azithromycin (As Dihydrate)
Dosage Form
Solution For Injection (Im/Iv)
Dosage Strength
500 mg
Manufacturer
Gufic Biosciences Limited
Importer
Ambica International Corporation
Distributor
Neo-Care Philippines
Company Detail Path
/organization/gufic-biosciences-limited
Issuance Date
26 October 2022
Expiry Date
01 April 2028
Pharmacologic Category
Antibacterial (Macrolide)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
69f9801b0dc9c9be
Type
Standard
Back to Philippines FDA Approvals
Berzimax-500 - Philippines FDA Drug Approval Details